About Inogen, Inc. 
Inogen, Inc.
Pharmaceuticals & Biotechnology
Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.
Company Coordinates 
Company Details
326 Bollay Dr , GOLETA CA : 93117-5550
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 44 Schemes (47.9%)
Foreign Institutions
Held by 57 Foreign Institutions (11.41%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Dr. Heath Lukatch
Independent Chairman of the Board
Mr. Scott Wilkinson
President, Chief Executive Officer, Director
Mr. Benjamin Anderson-Ray
Independent Director
Mr. Scott Beardsley
Independent Director
Mr. R. Scott Greer
Independent Director
Mr. Raymond Huggenberger
Independent Director
Mr. Loren McFarland
Independent Director
Revenue and Profits:
Net Sales:
92 Million
(Quarterly Results - Jun 2025)
Net Profit:
-4 Million
Pharmaceuticals & Biotechnology
USD 228 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.60
-12.08%
1.15






